NASDAQ:RELV

Reliv International Stock Forecast, Price & News

$3.16

-0.24 (-7.06 %)

(As of 09/18/2020 12:00 AM ET)

Add

Compare

Today's Range

$3.16

Now: $3.16▼

$3.16

50-Day Range

$3.09

MA: $3.50▼

$4.32

52-Week Range

$2.60

Now: $3.16▼

$7.75

Volume274 shs

Average Volume18,588 shs

Market Capitalization$5.52 million

P/E RatioN/A

Dividend YieldN/A

Beta0.04

Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Reliv International.

2.7 Community Rank

Outperform Votes
Reliv International has received 104 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Reliv International has received 89 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Reliv International has received 53.89% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote “Outperform” if you believe RELV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Reliv International does not currently pay a dividend.
Dividend Growth
Reliv International does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Reliv International insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 31.18% of the stock of Reliv International is held by insiders.
Percentage Held by Institutions
Only 7.95% of the stock of Reliv International is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Reliv International is -28.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Reliv International is -28.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Reliv International has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.67 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorConsumer Staples

Current SymbolNASDAQ:RELV

Previous Symbol

CUSIPN/A

CIK768710

Webwww.reliv.com

Phone636-537-9715

Debt

Debt-to-Equity Ratio0.05

Current Ratio1.70

Quick Ratio1.04

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$35.06 million

Price / Sales0.16

Cash Flow$0.08 per share

Price / Cash Flow41.29

Book Value$6.36 per share

Price / Book0.50

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-440,000.00

Net Margins-0.61%

Return on Equity-1.89%

Return on Assets-1.31%

Miscellaneous

Employees156

Outstanding Shares1,746,000

Market Cap$5.52 million

Next Earnings Date11/12/2020 (Estimated)

OptionableNot Optionable

$3.16

-0.24 (-7.06 %)

(As of 09/18/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

Reliv International (NASDAQ:RELV) Frequently Asked Questions

How has Reliv International's stock been impacted by Coronavirus?

Reliv International's stock was trading at $3.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RELV shares have decreased by 2.8% and is now trading at $3.16.
View which stocks have been most impacted by COVID-19.

When is Reliv International's next earnings date?

Reliv International is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Reliv International.

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) released its quarterly earnings data on Friday, August, 14th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $8.02 million for the quarter. Reliv International had a negative net margin of 0.61% and a negative return on equity of 1.89%.
View Reliv International's earnings history.

Are investors shorting Reliv International?

Reliv International saw a decrease in short interest in August. As of August 31st, there was short interest totaling 4,200 shares, a decrease of 23.6% from the August 15th total of 5,500 shares. Based on an average daily volume of 8,400 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.4% of the company's stock are short sold.
View Reliv International's Short Interest.

Who are some of Reliv International's key competitors?

Some companies that are related to Reliv International include Acasti Pharma (ACST), Intec Pharma (NTEC), Guardion Health Sciences (GHSI), Histogen (HSTO), Regulus Therapeutics (RGLS), AEterna Zentaris (AEZS), Cyclacel Pharmaceuticals (CYCC), Adial Pharmaceuticals (ADIL), Eyegate Pharmaceuticals (EYEG), MYOS (MYOS), Novus Therapeutics (NVUS), DelMar Pharmaceuticals (DMPI), Salarius Pharmaceuticals (SLRX), IntelGenx Technologies (IGXT) and Bio-Path (BPTH).
View all competitors.

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include VIVUS (VVUS), Aquestive Therapeutics (AQST), Putnam Premier Income Trust (PPT), Rite Aid (RAD), RadNet (RDNT), Rexahn Pharmaceuticals (REXN), Rigel Pharmaceuticals (RIGL), RTI Surgical (RTIX), Sonoma Pharmaceuticals (SNOA) and Sunesis Pharmaceuticals (SNSS).

Who are Reliv International's key executives?

Reliv International's management team includes the following people:

Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.16.

How big of a company is Reliv International?

Reliv International has a market capitalization of $5.52 million and generates $35.06 million in revenue each year. Reliv International employs 156 workers across the globe.

What is Reliv International's official website?

The official website for Reliv International is www.reliv.com.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings